340 related articles for article (PubMed ID: 35173525)
1. Human Organoids as a Promising Platform for Fighting COVID-19.
Chen D; Su X; Chen H; Chen S; Zhao Y; Wei W
Int J Biol Sci; 2022; 18(3):901-910. PubMed ID: 35173525
[TBL] [Abstract][Full Text] [Related]
2. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
[TBL] [Abstract][Full Text] [Related]
3. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery.
Giani AM; Chen S
Stem Cell Res; 2021 May; 53():102207. PubMed ID: 33677394
[TBL] [Abstract][Full Text] [Related]
4. Defense of COVID-19 by Human Organoids.
Lv T; Meng F; Yu M; Huang H; Lin X; Zhao B
Phenomics; 2021; 1(3):113-128. PubMed ID: 35233559
[TBL] [Abstract][Full Text] [Related]
5. Lung Organoids as Model to Study SARS-CoV-2 Infection.
Peng L; Gao L; Wu X; Fan Y; Liu M; Chen J; Song J; Kong J; Dong Y; Li B; Liu A; Bao F
Cells; 2022 Sep; 11(17):. PubMed ID: 36078166
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells.
Dawoody Nejad L; Julian LM
Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859
[TBL] [Abstract][Full Text] [Related]
7. Organoid and microfluidics-based platforms for drug screening in COVID-19.
Ramezankhani R; Solhi R; Chai YC; Vosough M; Verfaillie C
Drug Discov Today; 2022 Apr; 27(4):1062-1076. PubMed ID: 34954328
[TBL] [Abstract][Full Text] [Related]
8. Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids.
Ng JH; Sun A; Je HS; Tan EK
Neuroscientist; 2023 Feb; 29(1):30-40. PubMed ID: 34036855
[TBL] [Abstract][Full Text] [Related]
9. Insights into organoid-based modeling of COVID-19 pathology.
Boroojerdi MH; Al Jabry T; Mirarefin SMJ; Albalushi H
Virol J; 2023 Feb; 20(1):37. PubMed ID: 36841795
[TBL] [Abstract][Full Text] [Related]
10. Human organoid models to study SARS-CoV-2 infection.
Han Y; Yang L; Lacko LA; Chen S
Nat Methods; 2022 Apr; 19(4):418-428. PubMed ID: 35396481
[TBL] [Abstract][Full Text] [Related]
11. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
[TBL] [Abstract][Full Text] [Related]
12. Histopathological features of SARS-CoV-2 infection and relationships with organoid technology.
İnanç İ; Erdemli E
J Int Med Res; 2021 Sep; 49(9):3000605211044382. PubMed ID: 34521239
[TBL] [Abstract][Full Text] [Related]
13. Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges.
Wang Y; Wang P; Qin J
Adv Sci (Weinh); 2022 Apr; 9(10):e2105187. PubMed ID: 35107217
[TBL] [Abstract][Full Text] [Related]
14. Development trends of human organoid-based COVID-19 research based on bibliometric analysis.
Li M; Yuan Y; Zou T; Hou Z; Jin L; Wang B
Cell Prolif; 2023 Dec; 56(12):e13496. PubMed ID: 37218396
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.
Chakrabarty K; Shetty R; Argulwar S; Das D; Ghosh A
Cytotherapy; 2022 Mar; 24(3):235-248. PubMed ID: 34656419
[TBL] [Abstract][Full Text] [Related]
16. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.
Jacob F; Pather SR; Huang WK; Zhang F; Wong SZH; Zhou H; Cubitt B; Fan W; Chen CZ; Xu M; Pradhan M; Zhang DY; Zheng W; Bang AG; Song H; Carlos de la Torre J; Ming GL
Cell Stem Cell; 2020 Dec; 27(6):937-950.e9. PubMed ID: 33010822
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.
Trevisan M; Riccetti S; Sinigaglia A; Barzon L
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
19. Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication.
Lui VC; Hui KP; Babu RO; Yue H; Chung PH; Tam PK; Chan MC; Wong KK
Sci Rep; 2022 Mar; 12(1):5375. PubMed ID: 35354880
[TBL] [Abstract][Full Text] [Related]
20. Airway and Alveoli Organoids as Valuable Research Tools in COVID-19.
de Oliveira M; De Sibio MT; Costa FAS; Sakalem ME
ACS Biomater Sci Eng; 2021 Aug; 7(8):3487-3502. PubMed ID: 34288642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
